Showing results (121-130 of 150) with videos related to
Sort By:
Pageof 15
The EMBO Journal|February 15, 2011
Structure of the Ire1 autophosphorylation complex and implications for the unfolded protein responseMaruf M U Ali, Tina Bagratuni, Emma L Davenport, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 16, 2013
Optimising measles virus-guided radiovirotherapy with external beam radiotherapy and specific checkpoint kinase 1 inhibitionYann Touchefeu, Aadil A Khan, Gerben Borst, et al.Antimicrobial Agents and Chemotherapy|September 18, 2013
Biological evaluation of benzothiazole ethyl urea inhibitors of bacterial type II topoisomerasesNeil R Stokes, Helena B Thomaides-Brears, Stephanie Barker, et al.Journal of Medicinal Chemistry|May 13, 2009
Novel orally bioavailable gamma-secretase inhibitors with excellent in vivo activityLinda E Keown, Ian Collins, Laura C Cooper, et al.The Journal of Biological Chemistry|September 22, 2005
Novel inhibitors of bacterial cytokinesis identified by a cell-based antibiotic screening assayNeil R Stokes, Jörg Sievers, Stephanie Barker, et al.Journal of Materials Chemistry. B|June 16, 2025
Towards the development of supramolecular self-associating amphiphiles as antibiofilm agents against Pseudomonas aeruginosa and Candida albicans biofilmsKira L F Hilton, Hendrik J F Steyn, Kusasalethu S Luthuli, et al.Journal of Medicinal Chemistry|April 19, 2002
3-Heteroaryl-2-pyridones: benzodiazepine site ligands with functional delectivity for alpha 2/alpha 3-subtypes of human GABA(A) receptor-ion channelsIan Collins, Christopher Moyes, William B Davey, et al.Journal of Medicinal Chemistry|April 30, 2010
Creating an antibacterial with in vivo efficacy: synthesis and characterization of potent inhibitors of the bacterial cell division protein FtsZ with improved pharmaceutical propertiesDavid J Haydon, James M Bennett, David Brown, et al.Journal of Medicinal Chemistry|October 13, 2010
Aminopyrazine inhibitors binding to an unusual inactive conformation of the mitotic kinase Nek2: SAR and structural characterizationDaniel K Whelligan, Savade Solanki, Dawn Taylor, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 21, 2014
Interrogating two schedules of the AKT inhibitor MK-2206 in patients with advanced solid tumors incorporating novel pharmacodynamic and functional imaging biomarkersTimothy A Yap, Li Yan, Amita Patnaik, et al.Pageof 15